Shares of Mylan were higher Monday after the drugmaker announced it will begin offering a generic version of its’ EpiPen for $300, representing a 50 percent discount from current prices.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
